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 I read with interest the two recent papers








 Clearly these offer recom-
mendations that should be heeded by all physicians involved
in the care of such patients. It is encouraging to see that
the topic of delirium is also receiving more general expo-
sure and is now being appreciated as a major problem for




With respect to other approaches for diagnosis and
management of delirium and the cost-effective aspects of




that demonstrated that a physician/nurse dementia team, al-
though very labor intensive, is medically and financially a
winner. We demonstrated that, for 12 control and 29 delir-
ious patients, a cooperative effort between a geriatric phy-
sician and an advanced practice geriatric nurse working
with geographically assigned house staff and primary nurse
care teams resulted in improved recognition of delirium
and achieved a shorter length of stay. Significant cost sav-
ings occurred over the 6-week period of the intervention
(approximately $57,000). Because of the small sample size
and short period of our intervention, we found no signifi-
cant differences in deaths, restraint or neuroleptic use, or
nursing home placement, which were all low in both groups.





tive efforts in this area are fruitful, and, although much re-
mains to be done, there is good reason to expect that ma-
jor improvements can be made in outcomes for such patients,
all we need to do is maintain our energy and focus.
 
James R. Webster Jr., MD
Department of Geriatric Medicine
Buehler Center on Aging
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et al. analyze dental and oral risk factors associated with





alyze dentate subjects and a group of dentate and edentu-
lous subjects. From their tables, it is possible to see that 28
of 218 dentate subjects (13%) and 22 of 140 (16%) eden-
tulous subjects developed AP. Although the rate is higher
in edentulous patients, in dentate patients, the more func-
tional units (opposing teeth) and the more decayed teeth
they had, the higher the risk.
Is the higher rate of aspiration pneumonia in patients
with no teeth due only to confounding, or is there an inde-
pendent (bad) effect of being edentulous?
 
Thomas E. Finucane, MD
Johns Hopkins Geriatric Center
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 The above letter was sent to the authors




 Dr. Finucane has noted that our data show a
difference in the cumulative incidence of aspiration pneu-
monia between dentate and edentulous participants. This
is seen on Table 2, displaying bivariate relationships be-
tween oral health characteristics and aspiration pneumonia.
In response to his observation, we tested the crude associa-
tion between complete edentulism and aspiration pneumo-
nia. We found no statistically significant difference for the
cumulative incidence of aspiration pneumonia in the den-










To test the final adjusted model for confounding due
to edentulism, we added a term for dentate versus edentu-
lous in our original logistic regression model. This term








 .48) and did not sub-
stantially change the coefficient estimates for the original
variables as presented in Table 4. Thus, our data do not
support confounding by edentulism.
In response to questions about the number of func-
tional units, we speculated in the paper on page 562 that
the number of functional units in the dentate may reflect a
greater surface area for plaque load. A further speculation
led to a supplemental analysis of the cumulative incidence
of aspiration pneumonia for the edentulous only. We found





 in the saliva. Although not tested in this study,
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 We read the article on appropriateness of




 Are they justified
in calling use of all drugs with a potential drug-drug and
drug-disease interaction inappropriate? We studied the
prevalence of a selected group of drugs with potential drug-





years). First, we identified patients admitted to the hospital
as a result of an adverse drug event. From this we chose the
four most-common groups of drugs with a potential drug-
drug or drug-disease interaction. These include use of anti-
depressants in cardiac disease, use of more than one drug
known to cause bradycardia, coprescription of amiodarone
and warfarin, and coprescription of nonsteroidal anti-inflam-
matory drugs and angiotensin-converting enzyme inhibitors.
Our study included older patients discharged from an
acute medical unit during a 4-month period in 1999. We
scrutinized the discharge prescriptions for any of the above-
mentioned combinations. Of 1,103 patients discharged dur-
ing this period, 132 (12%) had 144 (13%) of these combina-
tions with a potential drug-drug or drug-disease interaction.
The results are shown in Table 1.
The results illustrate that, even after careful review of
their medications, a significant number of patients were dis-
charged on drugs with potential drug-drug or drug-disease
interactions. So these combinations were considered ap-
propriate by their physicians, albeit unsafe because of the
nature of their medical problems. Hence, we would like to
disagree with the finding of Giron et al. that all unsafe com-
binations they found in their study were inappropriate. Un-
less a detailed review of the patients and their medications is
made, the inappropriateness of the use of drugs with poten-
tial interactions cannot be judged. They have considered
using a beta-blocker in cardiac failure as inappropriate,
whereas we now have enough evidence to support their use.
It is also interesting to note the absence of antidepressants,
warfarin, and amiodarone in any of the potential drug-drug
and drug-disease interactions reported in their study. A pos-
sible reason could be that amiodarone and warfarin were
not as widely used during their study period (1994–96) as
they are now. Prescribing in older people is a difficult task,
and use of drugs with potential drug-drug and drug-disease
interactions is unavoidable in a majority of patients because
the presence of multiple pathologies.
 
Vedamurthy Adhiyaman, MRCP
Department of Geriatric Medicine
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The above letter was sent to the authors




 We appreciate the interest of Adhiyaman et al.
in our study. The letter points to some of the limitations in
performing population-based studies. Our findings were de-
rived from the analysis of secondary data. As such, our ob-
jectives were pursued within the limits of data collected for
other purposes. Additionally, the data for this study was
collected over a period of 2 years, 1994–96, and so drug in-
formation would be based on what was used at the time of
interview. Finally, as in most cross-sectional studies, the
duration and chronicity of drug use cannot be ascertained
with complete accuracy.
We agree with the assertion of Adhiyaman et al. that
prescribing for older people is fraught with difficulties be-
cause multiple pathology, which allows for the prescrip-
tion of drugs with contraindications or potential for inter-
action, is more often the rule. We were therefore prudent
in interpreting the results of our findings by stating that we
found substantial exposure to presumptively inappropriate
use of drugs in this very old population (Discussion, page
281, paragraph 3, and Conclusion, page 282, paragraph
1). The contention of Adhiyaman et al. as to whether we
were justified in calling all potential drug-drug and drug-
 






Antidepressants in cardiac disease 75 (6.8)
Tricyclic antidepressants 42
Selective serotonin reuptake inhibitors 32
Others 1



































 warfarin 26 (2.3)




angiotensin converting enzyme inhibitors 5 (0.5)
Total 144 (13)
